Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Higher Late Afternoon

Sector Update: Healthcare Stocks Higher Late Afternoon

MT newswireMT newswire2026/09/17 19:44
03:44 PM EDT, 09/17/2026 (MT Newswires) -- Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index adding 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.6%. The iShares Biotechnology ETF (IBB) climbed 2%. In corporate news, Pfizer's (PFE) Canadian operation Pfizer Canada ULC and BioNTech (BNTX) said Thursday that Health Canada has authorized XFG-adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. Pfizer shares added 0.5%, and BioNTech gained 2.8%. Medical Properties Trust (MPT) shares rose 8% in Thursday trading, a day after the company completed the sale of two Idaho hospital properties to affiliates of Intermountain Health for $413 million. Novo Nordisk (NVO) and Orbis Medicines struck an up to $1.4 billion licensing deal for the private company to develop oral drugs for cardiometabolic diseases. Novo will also make a "strategic investment" in Orbis. Separately, Novo said Thursday that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization for Frehemgo or denecimig in the EU to treat haemophilia A, a bleeding disorder. Novo shares rose 3.9%. Nuvation Bio (NUVB) shares gained 5.3% after the company said the US Food and Drug Administration has approved its supplemental new drug application for taletrectinib to treat non-small cell lung cancer.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation

Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.

智通财经•2026/09/29 11:06

The United States relaxes fuel standards, significantly reducing technology costs for automakers: General Motors (GM.US) is expected to save 20.4 billion dollars, and the price per vehicle may drop by nearly 1,300 dollars.

The United States has relaxed fuel economy standards, allowing automakers to save $60.6 billions in technology costs by 2031, with the cost per vehicle expected to decrease by $1,289.

智通财经•2026/09/29 11:02